OBJECTIVE: To systematically review evaluations of the impact of sexually transmissible infection (STI) programs delivered by primary health care services in remote Aboriginal communities. METHODS: PubMed, Google Scholar, InfoNet, Cochrane Controlled Trials Register, Australian New Zealand Clinical Trial Registry, conference proceedings and bulletins were searched to April 2011 using variations of the terms 'Aboriginal', 'programs' and 'STI'. The primary outcome of interest in the review was the change in bacterial STI infection prevalence in the target age group assessed through cross-sectional screening studies over a 5-year period or more. The characteristics of the primary health care service, STI programs and other clinical service outcomes were also described. RESULTS: Twelve reports described four distinct STI programs in remote communities and their impact on STI prevalence. In the Anangu Pitjantjatjara Yankunytjatjara (APY) lands of northern South Australia, there was a reduction in the age-adjusted chlamydia and gonorrhoea prevalence by 58% and 67%, respectively (1996-2003). In the Tiwi Islands of Northern Territory (NT), chlamydia and gonorrhoea positivity decreased by 94% and 34%, respectively (2002-2005). In the Ngaanyatjarra Lands of Western Australia, crude chlamydia and gonorrhoea prevalence decreased by 36% and 48%, respectively (2001-2005), and in the central Australian region of NT, there was no sustained decline in crude prevalence (2001-2005). CONCLUSION: In three of the four programs, there was some evidence that clinical best practice and well coordinated sexual health programs can reduce STI prevalence in remote Aboriginal communities.
OBJECTIVE: To systematically review evaluations of the impact of sexually transmissible infection (STI) programs delivered by primary health care services in remote Aboriginal communities. METHODS: PubMed, Google Scholar, InfoNet, Cochrane Controlled Trials Register, Australian New Zealand Clinical Trial Registry, conference proceedings and bulletins were searched to April 2011 using variations of the terms 'Aboriginal', 'programs' and 'STI'. The primary outcome of interest in the review was the change in bacterial STI infection prevalence in the target age group assessed through cross-sectional screening studies over a 5-year period or more. The characteristics of the primary health care service, STI programs and other clinical service outcomes were also described. RESULTS: Twelve reports described four distinct STI programs in remote communities and their impact on STI prevalence. In the Anangu Pitjantjatjara Yankunytjatjara (APY) lands of northern South Australia, there was a reduction in the age-adjusted chlamydia and gonorrhoea prevalence by 58% and 67%, respectively (1996-2003). In the Tiwi Islands of Northern Territory (NT), chlamydia and gonorrhoea positivity decreased by 94% and 34%, respectively (2002-2005). In the Ngaanyatjarra Lands of Western Australia, crude chlamydia and gonorrhoea prevalence decreased by 36% and 48%, respectively (2001-2005), and in the central Australian region of NT, there was no sustained decline in crude prevalence (2001-2005). CONCLUSION: In three of the four programs, there was some evidence that clinical best practice and well coordinated sexual health programs can reduce STI prevalence in remote Aboriginal communities.
Authors: Ben B Hui; Nathan Ryder; Jiunn-Yih Su; James Ward; Marcus Y Chen; Basil Donovan; Christopher K Fairley; Rebecca J Guy; Monica M Lahra; Mathew G Law; David M Whiley; David G Regan Journal: PLoS One Date: 2015-07-16 Impact factor: 3.240
Authors: L Natoli; R J Guy; M Shephard; D Whiley; S N Tabrizi; J Ward; D G Regan; S G Badman; D A Anderson; J Kaldor; L Maher Journal: BMJ Open Date: 2015-04-28 Impact factor: 2.692
Authors: James Ward; Skye McGregor; Rebecca J Guy; Alice R Rumbold; Linda Garton; Bronwyn J Silver; Debbie Taylor-Thomson; Belinda Hengel; Janet Knox; Amalie Dyda; Matthew G Law; Handan Wand; Basil Donovan; Christopher K Fairley; Steven Skov; Donna Ah Chee; John Boffa; David Glance; Robyn McDermott; Lisa Maher; John M Kaldor Journal: BMC Infect Dis Date: 2013-09-09 Impact factor: 3.090
Authors: Lisa Natoli; Lisa Maher; Mark Shephard; Belinda Hengel; Annie Tangey; Steven G Badman; James Ward; Rebecca J Guy Journal: PLoS One Date: 2014-06-23 Impact factor: 3.240
Authors: Lisa Natoli; Rebecca J Guy; Mark Shephard; Louise Causer; Steven G Badman; Belinda Hengel; Annie Tangey; James Ward; Tony Coburn; David Anderson; John Kaldor; Lisa Maher Journal: PLoS One Date: 2015-12-29 Impact factor: 3.240
Authors: Ben B Hui; Richard T Gray; David P Wilson; James S Ward; Anthony M A Smith; David J Philip; Matthew G Law; Jane S Hocking; David G Regan Journal: BMC Infect Dis Date: 2013-04-25 Impact factor: 3.090
Authors: Joanne Reekie; Basil Donovan; Rebecca Guy; Jane S Hocking; Louisa Jorm; John M Kaldor; Donna B Mak; David Preen; Sallie Pearson; Christine L Roberts; Louise Stewart; Handan Wand; James Ward; Bette Liu Journal: PLoS One Date: 2014-04-17 Impact factor: 3.240
Authors: Rebecca J Guy; Lisa Natoli; James Ward; Louise Causer; Belinda Hengel; David Whiley; Sepehr N Tabrizi; Basil Donovan; Christopher K Fairley; Steven B Badman; Annie Tangey; Handan Wand; Mark Shephard; David G Regan; David Wilson; David Anderson; John M Kaldor Journal: BMC Infect Dis Date: 2013-10-18 Impact factor: 3.090
Authors: Belinda Hengel; Stephen Bell; Linda Garton; James Ward; Alice Rumbold; Debbie Taylor-Thomson; Bronwyn Silver; Skye McGregor; Amalie Dyda; Janet Knox; Rebecca Guy; Lisa Maher; John Martin Kaldor Journal: BMC Health Serv Res Date: 2018-04-02 Impact factor: 2.655